Burden of prostate cancer in China during 1990-2021 and the projections through 2050.

ABSTRACT:

Background

To provide the most up-to-date data on the burden of prostate cancer (PC) in China and the projections through 2050.

Methods

Using the Global Burden of Disease (GBD) database 2021, we investigated the characteristics of PC burden in China, including temporal trends in incidence, prevalence, mortality, and disability-adjusted life years (DALYs). Age-period-cohort models, frontier analysis, decomposition analysis and prediction models were used for data analyze.

Results

In 2021, the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) reached 9.34, 59.86, 4.89, and 76.97 (per 100 000), respectively. The ASIR and ASPR in 2021 increased by 87.17 % and 209.

SUBMITTER: Hua L 

PROVIDER: S-EPMC12746279 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature